J. Aldigier

发表

The renal epidemiology and information network (REIN): a new registry for end-stage renal disease in France.

Paul Landais, Christian Jacquelinet, Michèle Kessler, 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Whole blood production of monocytic cytokines (IL-1beta, IL-6, TNF-alpha, sIL-6R, IL-1Ra) in haemodialysed patients.

V. Praloran, J. Aldigier, Y. Le Meur, 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Low incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the French national cohort of dialysis patients

E. M. Passos, L. Duflot, M. Brahimi, 2020, Kidney International.

The clinical status and survival in elderly dialysis: example of the oldest region of France

Florence Glaudet, C. Couchoud, J. Aldigier, 2013, BMC Nephrology.

Molecular study of an IgG1κ cryoglobulin yielding organized microtubular deposits and glomerulonephritis in the course of chronic lymphocytic leukaemia

M. Cogné, F. Paraf, J. Aldigier, 2002 .

Protection of Renal Function with ACE Inhibitors

J. Aldigier, Y. Meur, P. Brunel, 1998, Clinical drug investigation.

Regression of glomerulosclerosis with high-dose angiotensin inhibition is linked to decreased plasminogen activator inhibitor-1.

C. Marcantoni, Li-jun Ma, Xiubin Liang, 2005, Journal of the American Society of Nephrology : JASN.

Plasma levels and metabolism of AcSDKP in patients with chronic renal failure: relationship with erythropoietin requirements.

V. Praloran, J. Aldigier, Y. Meur, 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Safety of the combination of valsartan and benazepril in patients with chronic renal disease

L. Ruilope, C. Ponticelli, J. Aldigier, 2000, Journal of hypertension.

Effect of renal function on the pharmacokinetics and pharmacodynamics of trandolapril.

R. Wilkinson, J. Aldigier, S. Harper, 1993, British journal of clinical pharmacology.

Specific impairment of proximal tubular cell proliferation by a monoclonal κ light chain responsible for Fanconi syndrome.

M. Cogné, J. Aldigier, F. Bridoux, 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

IgA Structure Variations Associate with Immune Stimulations and IgA Mesangial Deposition.

Zeliha Oruc, M. Cogné, J. Demengeot, 2016, Journal of the American Society of Nephrology : JASN.

Deregulated platelet-activating factor levels and acetylhydrolase activity in patients with idiopathic IgA nephropathy.

M. Cogné, J. Aldigier, Y. Denizot, 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Is plasma Ac-SDKP level a reliable marker of chronic angiotensin-converting enzyme inhibition in hypertensive patients?

V. Praloran, J. Aldigier, Y. Le Meur, 1998, Hypertension.

Mesangial Deposition Can Strongly Involve Innate-Like IgA Molecules Lacking Affinity Maturation.

M. Cogné, F. Paraf, J. Aldigier, 2019, Journal of the American Society of Nephrology : JASN.

Gammopathy with IgA mesangial deposition provides a monoclonal model of IgA nephritogenicity and offers new insights into its molecular mechanisms.

Zeliha Oruc, M. Cogné, J. Aldigier, 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

A Familial C3GN Secondary to Defective C3 Regulation by Complement Receptor 1 and Complement Factor H.

J. Atkinson, J. Aldigier, V. Frémeaux-Bacchi, 2016, Journal of the American Society of Nephrology : JASN.

Direct radioimmunoassays of renin and renin substrate during converting-enzyme inhibition.

J. Ménard, P. Corvol, J. Aldigier, 1982, Clinical and experimental hypertension. Part A, Theory and practice.

Angiotensin‐Converting Enzyme Inhibition Does Not Suppress Plasma Angiotensin II Increase During Exercise in Humans

T. Baussant, J. Aldigier, C. Leroux-Robert, 1993, Journal of cardiovascular pharmacology.

Effects of the angiotensin‐converting enzyme inhibitor enalapril on blood haematopoietic progenitors and Acetyl‐N‐Ser‐Asp‐Lys‐Pro concentrations

V. Praloran, J. Aldigier, V. Lorgeot, 1997, European journal of clinical investigation.

Dose Dependency of Captopril Effects in Severely Hypertensive Patients

J. Ménard, P. Corvol, J. Aldigier, 1981, Journal of cardiovascular pharmacology.

Serum levels of macrophage-colony stimulating factor (M-CSF): a marker of kidney allograft rejection.

V. Praloran, J. Aldigier, J. Dantal, 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Macrophage colony stimulating factor involvement in uremic patients.

V. Praloran, J. Aldigier, Y. Le Meur, 1996, Kidney international.

M-CSF serous rate evolution during post-transplantation days in a heterotopic heart graft model mice.

J. Aldigier, C. Christides, P. Virot, 1997, The Journal of cardiovascular surgery.

Bromodomain and extraterminal (BET) protein inhibition of IgG/IgE production in murine B cells is counter‐balanced by a strong Th2 bias

B. Ryffel, M. Cogné, N. Fazilleau, 2021, Clinical & translational immunology.

Acute renal failure in a marathon runner: role of glomerular bleeding intubular injury

F. Paraf, J. Aldigier, Y. Meur, 1998 .

Regulation of the Immune Response by Eicosanoid Acids

N. Gualde, J. Aldigier, J. Goodwin, 1985 .

Influence of endogenous opioids on atrial natriuretic factor release during exercise in man

F. Louisy, C. Guézennec, J. Aldigier, 2006, European Journal of Applied Physiology and Occupational Physiology.

Minimization of maintenance immunosuppressive therapy after renal transplantation comparing cyclosporine A/azathioprine or cyclosporine A/mycophenolate mofetil bitherapy to cyclosporine A monotherapy: a 10‐year postrandomization follow‐up study

J. Aldigier, M. Essig, B. Hurault de Ligny, 2016, Transplant international : official journal of the European Society for Organ Transplantation.

Comparison of the hormonal and renal effects of captopril in severe essential and renovascular hypertension.

J. Ménard, P. Corvol, J. Aldigier, 1982, The American journal of cardiology.

Modulation of Fcγ receptors on T cells and monocytes by 15 hydroperoxyeicosatetranoic acid

N. Gualde, J. Aldigier, M. Rigaud, 1984 .

Restenotic process and DD genotype after angiotensin-converting enzyme inhibitor treatment

C. Tribouilloy, J. Achard, L. Leborgne, 2001, The Lancet.

ROLE OF THE MONOCLONAL κ CHAIN V DOMAIN AND REVERSIBILITY OF RENAL DAMAGE IN A TRANSGENIC MODEL OF ACQUIRED FANCONI’S SYNDROME

O. Devuyst, J. Aldigier, J. Goujon, 2006 .

Intracranial granuloma and skull osteolysis: complication of a primary cutaneous cryptococcosis in a kidney transplant recipient.

F. Paraf, J. Aldigier, Y. Le Meur, 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Bordetella holmesii bacteremia in a renal transplant recipient: emergence of a new pathogen

J. Aldigier, M. Essig, O. Barraud, 2012, Transplant infectious disease : an official journal of the Transplantation Society.

INSIGHT and NORDIL

J. Achard, J. Aldigier, N. Oudart, 2000, The Lancet.

NZB/NZW F1 mouse nephritis and immune response are not changed by treatment with a 15-lipoxygenase derivative.

M. Juzan, N. Gualde, J. Aldigier, 1992, Prostaglandins, leukotrienes, and essential fatty acids.

15-HETE "modulates" expression of C3b receptor (CR1) antigen on peripheral blood B-lymphocytes.

M. Kazatchkine, N. Gualde, J. Aldigier, 1986, Prostaglandins, leukotrienes, and medicine.

Whole blood production of monocytic cytokines (IL-1β, IL-6, TNF-α, sIL-6R, IL-1Ra) in haemodialysed patients

V. Praloran, J. Aldigier, Y. Meur, 1999 .

History of IgA Nephropathy Mouse Models

M. Cogné, J. Aldigier, Virginie Pascal, 2021, Journal of clinical medicine.

Acquired ichthyosis and pyoderma gangrenosum in a patient with systemic lupus erythematosus

J. Bonnetblanc, J. Aldigier, C. Leroux-Robert, 1993, Clinical and experimental dermatology.

Role of the monoclonal kappa chain V domain and reversibility of renal damage in a transgenic model of acquired Fanconi syndrome.

M. Cogné, O. Devuyst, J. Aldigier, 2006, Blood.

Locus suicide recombination actively occurs on the functionally rearranged IgH allele in B-cells from inflamed human lymphoid tissues

T. Fest, A. Durandy, M. Cogné, 2018, bioRxiv.

Detecting Rare AID-Induced Mutations in B-Lineage Oncogenes from High-Throughput Sequencing Data Using the Detection of Minor Variants by Error Correction Method

E. Pinaud, M. Cogné, J. Aldigier, 2018, The Journal of Immunology.

Thymocyte cyclic AMP and cyclic GMP response to treatment with metabolites issued from the lipoxygenase pathway.

N. Gualde, J. Aldigier, M. Rigaud, 1985, Journal of immunology.

Immunosuppression induced in vivo by 15 hydroxyeicosatetraenoic acid (15 HETE).

N. Gualde, J. Aldigier, M. Ratinaud, 1984, Prostaglandins, leukotrienes, and medicine.

G-quadruplex DNA targeting alters class-switch recombination in B cells and attenuates allergic inflammation.

B. Ryffel, M. Cogné, J. Mergny, 2018, The Journal of allergy and clinical immunology.

PAI-1 donor polymorphism influences long-term kidney graft survival.

P. Preux, J. Aldigier, Y. Le Meur, 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Molecular study of an IgG1kappa cryoglobulin yielding organized microtubular deposits and glomerulonephritis in the course of chronic lymphocytic leukaemia.

M. Cogné, F. Paraf, J. Aldigier, 2002, Clinical and Experimental Immunology.

Crystal-storing histiocytosis with renal Fanconi syndrome: pathological and molecular characteristics compared with classical myeloma-associated Fanconi syndrome.

M. Cogné, P. Trouillas, J. Aldigier, 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Impact of prior CKD management in a renal care network on early outcomes in incident dialysis patients: a prospective observational study

F. Vrtovsnik, B. Vendrely, C. Combe, 2013, BMC Nephrology.

New clinical forms of hereditary apoA-I amyloidosis entail both glomerular and retinal amyloidosis.

N. Rioux-Leclercq, D. Samuel, F. Paraf, 2020, Kidney international.

Molecular basis for a novel systemic form of human hereditary apoA-I amyloidosis with vision loss

J. Straub, N. Rioux-Leclercq, F. Paraf, 2018, bioRxiv.

Regression of existing glomerulosclerosis by inhibition of aldosterone.

Li-jun Ma, N. Brown, A. Fogo, 2005, Journal of the American Society of Nephrology : JASN.

Systemic lupus erythematosus syndrome induced by pindolol.

N. Gualde, J. Aldigier, J. Bensaid, 1979, British medical journal.

The effect of renal impairment on the pharmacokinetics of oxcarbazepine and its metabolites

P. Jungers, J. Aldigier, M. Rouan, 1994, European Journal of Clinical Pharmacology.

CSReport: A New Computational Tool Designed for Automatic Analysis of Class Switch Recombination Junctions Sequenced by High-Throughput Sequencing

M. Cogné, J. Aldigier, C. Carrion, 2017, The Journal of Immunology.

PAF and hematopoiesis. VIII. Biosynthesis and metabolism of PAF by human bone marrow stromal cells.

V. Praloran, J. Aldigier, C. Verger, 1996, Experimental hematology.

C.E.R.A. safety profile: a pooled analysis in patients with chronic kidney disease.

F. C. Dougherty, F. Locatelli, J. Aldigier, 2010, Clinical nephrology.

Aliskiren, an orally effective renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan.

Roland E Schmieder, Andrzej Januszewicz, R. Schmieder, 2007, American journal of hypertension.

Diagnosis of left ventricular diastolic dysfunction in the setting of acute changes in loading conditions

J. Aldigier, P. Vignon, B. François, 2007, Critical care.

Polymorphism of the human α1 immunoglobulin gene 3′ enhancer hs1,2 and its relation to gene expression

E. Pinaud, M. Cogné, J. Aldigier, 2001, Immunology.

Renal infarction and thrombosis of the infrarenal aorta in a 35-year-old man with primary antiphospholipid syndrome.

J. Aldigier, C. Leroux-Robert, P. Lacroix, 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

When the kidney catches a cold: an unusual cause of acute renal failure.

J. Aldigier, F. Soulis, C. Hottelart, 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

The Tinu Syndrome or the Sjögren Syndrome?

J. Aldigier, A. Rogues, E. Vidal, 1992, Annals of Internal Medicine.

Development of a risk stratification algorithm to improve patient-centered care and decision making for incident elderly patients with end-stage renal disease.

C. Couchoud, J. Aldigier, P. Brunet, 2015, Kidney international.

Severe sirolimus‐induced acute hepatitis in a renal transplant recipient

J. Aldigier, M. Essig, P. Carrier, 2010, Transplant international : official journal of the European Society for Organ Transplantation.

An unusual pulmonary complication of cytomegalovirus infection in a renal transplant recipient

J. Aldigier, M. Essig, A. Dallocchio, 2008, NDT plus.

Equity of Accessibility to Dialysis Facilities

Mohamed Ben Saïd, Paul Landais, Jean-Baptiste Richard, 2009, MIE.

Alleles of the alpha1 immunoglobulin gene 3' enhancer control evolution of IgA nephropathy toward renal failure.

E. Pinaud, M. Cogné, J. Aldigier, 2000, Kidney international.

Role of the monoclonal kappa chain V domain and reversibility of renal damage in a transgenic model of acquired Fanconi syndrome.

M. Cogné, J. Aldigier, J. Goujon, 2006, Blood.

The renal epidemiology and information network (REIN): a new registry for end-stage renal disease in France.

C. Jacquelinet, B. Stengel, P. Landais, 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Specific impairment of proximal tubular cell proliferation by a monoclonal κ light chain responsible for Fanconi syndrome.

M. Cogné, J. Aldigier, F. Bridoux, 2012, Nephrology, Dialysis and Transplantation.

Controlled trial of azathioprine and plasma exchange in addition to prednisolone in the treatment of bullous pemphigoid.

L. Vaillant, J. Roujeau, J. Aldigier, 1993, Archives of dermatology.

Specific binding of 15 HETE to lymphocytes. Effects on the fluidity of plasmatic membranes.

N. Gualde, J. Aldigier, M. Rigaud, 1984, Prostaglandins, leukotrienes, and medicine.